Ramani S Wonderling
Inventor
Stats
- 16 US patents issued
- 17 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 16 US Patents Issued
- 17 US Applications Filed
- 25 Total Citation Count
- Jun 21, 2010 Most Recent Filing
- May 28, 1999 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| WELLS FARGO BUSINESS CREDIT, INC., A DELAWARE CORPORATION | 2
2 2 1 1 | 2002
2004 2006 2007 2008 |
| WELLS FARGO BANK, NATIONAL ASSOCIATION | 1
| 2006
|
| ABBOTT LABORATORIES | 2
2 | 2005
2008 |
| ABBOTT LABORATORIES | 1
| 2009
|
| Heska Corporation | 2
3 1 2 3 1 1 2 | 1999
2001 2002 2004 2006 2007 2008 2010 |
Inventor Addresses
| Address | Duration |
|---|---|
| Fort Collins, CO | Oct 29, 02 - Sep 28, 06 |
| Fort Collins, CO, US | May 29, 03 - Jul 31, 03 |
| Ivanhoe, IL | Aug 10, 06 - Aug 10, 06 |
| Ivanhoe, IL, US | Dec 10, 09 - Oct 16, 12 |
| Mundelein, IL | Jan 11, 07 - Mar 15, 07 |
| Mundelein, IL, US | Jul 07, 09 - Sep 11, 12 |
| Waukegan, IL | Aug 03, 04 - Jan 01, 08 |
| Waukegan, IL, US | May 02, 02 - Oct 04, 11 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 11 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 12 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 8288124 | 2012 | Cloning, expression and purification of recombinant porcine intrinsic factor for use in diagnostic assay | 0 |
| 8263559 | 2012 | Feline granulocyte macrophage colony stimulating factor proteins | 0 |
| 8029776 | 2011 | Cationic lipid-mediated enhancement of nucleic acid immunization of cats | 0 |
| 7932369 | 2011 | Diagnostic test for vitamin B.sub.12 | 0 |
| 7928197 | 2011 | Feline IL-18 proteins | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. > Upgrade to our Level for up to -1 portfolios!.